Why rare-disease drugs could become India’s next pharma frontier
India is looking to expand its pharmaceutical strengths into rare‑disease medicines. Officials say the country can leverage its low‑cost drug model by creating a clear regulatory framework, offering financial incentives and using government procurement to attract manufacturers. The goal is to make treatments for uncommon conditions more accessible worldwide and position India as a competitive supplier.